Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.
Kaeberich A, Reindl I, Raaz U, Maegdefessel L, Vogt A, Linde T, Steinseifer U, Perzborn E, Hauroeder B, Buerke M, Werdan K, Schlitt A. Kaeberich A, et al. Among authors: werdan k. J Thromb Thrombolysis. 2011 Nov;32(4):417-25. doi: 10.1007/s11239-011-0621-6. J Thromb Thrombolysis. 2011. PMID: 21773837
In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis.
Kaeberich A, Raaz U, Vogt A, Maedgefessel L, Neuhart E, Krezel C, Drouget L, Hauroeder B, Buerke M, Werdan K, Schlitt A. Kaeberich A, et al. Among authors: werdan k. J Thromb Thrombolysis. 2014;37(2):118-30. doi: 10.1007/s11239-013-0938-4. J Thromb Thrombolysis. 2014. PMID: 23821043 Clinical Trial.
526 results